Medicus Sciences Acquisition (MSAC) Annual Income Statement

Annual · GAAP · USD millions
Access MSAC quarterly income statements →
Income statement data covering Medicus Sciences Acquisition– offers a view into how Dec 31 2021's operating results have moved alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
2021
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Other Operating Expense / -Income0.61
Total operating costs including COS0.61
Operating income / -loss-0.61
Net Interest (-)Expense / Income0.01
Investment Income, Interest-0.01
Other loss / -income-2.50
Total costs & expenses-1.90
Income & Taxes
Income / -loss before income taxes1.90
Income after income taxes1.90
Income / -loss from continuing operations1.90
Net income / -loss1.90
Income / -loss to shareholder-6.66
EBIT1.89
EBITD1.89
EBITDA1.89
Earnings Per Share
Basic EPS (excl. extra items)0.18
Basic Net EPS0.18
Basic shares outstanding (Mill. of Units)8.04
Diluted Net EPS0.18
Diluted average shares (Mill. of Units)8.04
4 historic quarters locked

Sign in to unlock the full Medicus Sciences Acquisition income statement history.

About MSAC Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI